Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

The Effectiveness of Guideline Implementation Strategies on Improving Antipsychotic Medication Management for Schizophrenia

Bibliographic Data

ID9101586
AuthorsRichard R Owen (0000-0003-2548-2264, Central Arkansas Veterans Healthcare System, corresponding author), Teresa J Hudson (0000-0002-6672-6774, Health Services Research & Development, corresponding author), Teresa Hudson, Carol R Thrush (0000-0002-1877-5002, Office of Education), Carol Thrush, Purushottam Thapa, Purushottam B Thapa (Behavioral Health Services), Tracey Armitage (Central Arkansas Veterans Healthcare System, corresponding author), Reid D Landes (0000-0002-6349-0081)
Year2008
Volume46
Issue7
Pages686-691
Publication date2008-07-01
Peer ReviewedYes
Open AccessNo
TypeARTICLE
VenueMedical Care (JOURNAL)
Journal identifiersISSN: 0025-7079 • E-ISSN: 1537-1948
PublisherOvid Technologies (Wolters Kluwer Health) (PUBLISHER)
DOI10.1097/mlr.0b013e3181653d43
PMID18580387
OpenAlexW2073143096
LanguageEN
Citations received3
References cited32

OBJECTIVES: To compare the effectiveness of a conceptually-based, multicomponent "enhanced" strategy with a "basic" strategy for implementing antipsychotic management recommendations of VA schizophrenia guidelines. METHODS: Two VA medical centers in each of 3 Veterans Integrated Service Networks were randomized to either a basic educational implementation strategy or the enhanced strategy, in which a trained nurse promoted provider guideline adherence and patient compliance. Patients with acute exacerbation of schizophrenia were enrolled and assessed at baseline and 6 months and their medical records were abstracted; 291 participants were included in analyses. Logistic regression models were developed for rates of: (1) switching patients from first-generation antipsychotics (FGA) to second-generation antipsychotics (SGA), and (2) guideline-concordant antipsychotic dose. RESULTS: Of participants prescribed FGAs at baseline, those at enhanced sites were significantly more likely than participants at basic sites to have an SGA added to the FGA during the study (29% vs. 8%; adjusted OR = 7.7; 95% CI: 2.0-30.1), but were not significantly more likely to be switched to monotherapy with an SGA (29% vs. 23%). Guideline-concordant antipsychotic dosing was not significantly affected by the intervention. CONCLUSIONS: The enhanced guideline implementation strategy increased addition of SGAs to FGA therapy, but did not significantly increase guideline-recommended switching from FGA to SGA monotherapy. Antipsychotic dosing was not significantly altered. The study illustrates the challenges of changing clinical behavior. Strategies to improve medication management for schizophrenia are needed, and must incorporate recommendations likely to emerge from recent research suggesting comparable effectiveness of SGAs and FGAs

Antipsychotic · Guideline · Medication adherence · MEDLINE · Political science · Psychiatry · Schizophrenia (object-oriented programming) · Health Policy Implementation Science · Healthcare Decision-Making and Restraints · Internal Medicine · Medicine · Schizophrenia research and treatment

  • Partnership for Implementation of Evidence-Based Mental Health Practices in Rural Federally Qualified Health Centers

    Justin Hunt, Geoffrey M Curran et al.•Progress in community health…•2012

  • Characteristics of Medicaid Recipients Receiving Persistent Antipsychotic Polypharmacy

    Open Access•Robert O Cotes, David R Goldsmith et al.•Community Mental Health Journal•2018

  • Effect of Introducing a Care Pathway to Standardize Treatment and Nursing of Schizophrenia

    Open Access•Sara Marchisio, Michele Vanetti et al.•Community Mental Health Journal•2009

  • Detecting Alcoholism

    John A Ewing•JAMA•1984

  • Patterns of Usual Care for Schizophrenia

    Anthony F Lehman, D M Steinwachs et al.•Schizophrenia Bulletin•1998

  • Translating Research Into Practice

    Anthony F Lehman, D M Steinwachs et al.•Schizophrenia Bulletin•1998

  • Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia

    Jeffrey A Lieberman, T Scott Stroup et al.•New England Journal of Medicine•2005

  • The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia

    Stanley R Kay, Abraham Fiszbein et al.•Schizophrenia Bulletin•1987

  • Changing Provider Behavior

    Jeremy M Grimshaw, Liz Shirran et al.•Medical Care•2001

  • Use of Pharmacy Data to Assess Quality of Pharmacotherapy for Schizophrenia in a National Health Care System

    Douglas L Leslie, Douglas Leslie et al.•Medical Care•2001

Unique citing works3
Citations per year0,18
Citation span2009 - 2018 (10)
Citation velocityhistorical
Highly citedNo
Citation typesNeutral: 2
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae